Skip to main content
. 2016 Mar;19(3):245–251.

Figure 3.

Figure 3

IL-6/β-actin ratio in control, hyperlipidemic, and adropin-treated groups of rats; * Shows significance between groups H and A (P≤0.05) (Mann Whitney U test); C: control, H: hyperlipidemic, A: adropin treatment groups, IL-6: Interleukin 6